What is ROIV's five-year median EV/Sales?

63.8x. Half of ROIV's weekly readings since August 2022 were higher and half were lower. This page has 220 weekly readings, from Aug 15, 2022 to Oct 26, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares ROIV only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Roivant Sciences Ltd (ROIV) valuation history

Health Care

$37.52

Latest weekly close · Market cap $27.0B

Roivant Sciences' EV/Sales is not ranked because its revenue over the last twelve months is too small to compare (as of Oct 30, 2026).

No P/E: earnings over the last twelve months are negative.
No P/S: recent financial data is missing.
No EV/EBITDA: recent financial data is missing.

No EV/Sales chart for ROIV right now

EV/Sales

n/mnot ranked

No EV/Sales rank: revenue is too small to compare.

Growth, last 12 months vs the year before

Revenue: -68%decelerating
EPS: n/m

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/Sales at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

ROIV EV/Sales at each year-end
Year-end	EV/Sales	5-year percentile
Dec 29, 2025	518.8×	98
Dec 30, 2024	25.6×	32
Dec 25, 2023	74.0×	37
Dec 26, 2022	86.7×	Too little history

Health Care peers on EV/Sales

Each percentile compares a stock with its own last five years.

Compare ROIV with peers

Health Care peers of ROIV on EV/Sales
Stock	EV/Sales	Versus its own history	5-year percentile
ABBVAbbVie	8.9×	Historically high	100
AMGNAmgen	7.7×	Historically high	98
ARWRArrowhead Pharmaceuticals Inc	11.6×	Within its usual range	32
BIIBBiogen	4.2×	Historically high	91
BMRNBioMarin Pharmaceutical Inc	4.3×	Below its usual range	29

Appears in

Sector: Health Care
Screens: Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on ROIV

No articles about ROIV yet. How valuation percentiles work

Loading peers and related research…

About this history

What is ROIV's current EV/Sales?: Roivant Sciences' EV/Sales is not ranked because its revenue over the last twelve months is too small to compare (as of Oct 30, 2026).
What is ROIV's five-year median EV/Sales?: 63.8x. Half of ROIV's weekly readings since August 2022 were higher and half were lower. This page has 220 weekly readings, from Aug 15, 2022 to Oct 26, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares ROIV only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.